Fast-tracked CTL: Rapid induction of potent anti-tumor killer T cells in situ (Retracted Article)

Fast-tracked CTL: Rapid induction of potent anti-tumor killer T cells in situ (Retracted Article)
复制标题

DOI:
10.1002/eji.200637002
复制
发表时间:
2007-07-01
影响因子:
5.4
通讯作者:
Pease, Larry R.
Pease, Larry R.
中科院分区:
医学3区
文献类型:
--
作者:
Heckman, Karin L.;Schenk, Erin L.;Pease, Larry R.

文献摘要

被引文献

相似文献

目前引发对肿瘤相关或过表达的自身抗原特异性的溶细胞T细胞应答的策略依赖于多次免疫和体外扩增方案。在这里,我们报告了在用IgM免疫调节剂B7-DC XAb治疗后仅6天,体内诱导活化的肿瘤特异性CD 8(+)CTL。在肿瘤攻击时对小鼠的抗体处理引发了有效的CTL,其特异性区分MHC相容性肿瘤。值得注意的是,这些效应细胞不是由幼稚CTL前体的广泛增殖产生的,尽管它们的诱导需要CD 4(+)T细胞的帮助和经典的B7共刺激信号。肿瘤靶点被识别并在细胞内裂解。MHC限制性穿孔素依赖性方式,表明这些快速诱导的效应子类似于传统定义的CTL,尽管发现没有引起效应子/记忆标志物CD 44和活化标志物CD 69表达的强烈增加。这些CTL在具有良好建立的肿瘤的动物中诱导,并导致抗肿瘤保护,强调了这种类型的效应T细胞群在癌症患者中的治疗潜力。
Current strategies to elicit cytolytic T cell responses specific for tumor- associated or over-expressed self antigens rely on multiple immunizations and in vitro expansion schemes. Here we report the in vivo induction of activated tumor-specific CD8(+) CTL just 6 days after treatment with the IgM immune modulator B7-DC XAb. Antibody treatment of mice at the time of tumor challenge elicited potent CTL with a specificity that distinguished between MHC-compatible tumors. Remarkably, these effector cells were not generated by the extensive proliferation of naive CTL precursors, though their induction required CD4(+) T cell help and classical B7 costimulatory signals. Tumor targets were recognized and lysed in an. MHC-restricted, perforin-dependent manner, indicating that these rapidly induced effectors resemble traditionally defined CTL, despite the finding that strong increases in the expression of the effector/memory marker CD44 and the activation marker CD69 were not elicited. These CTL were induced in animals bearing well-established tumors and resulted in anti-tumor protection, underscoring the therapeutic potential of this type of effector T cell population in cancer patients.